The National Academies Press

Currently Skimming:

Index
Pages 193-200

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.

From page 193... ... , 21 Benefit amounts, and initial allowances, 17 Advanced Notice of Proposed Rulemaking Benton Visual Retention Test, 28 (ANPRM) , 23–24, 148 Blindness, 2n, 16n Age factors, 34 Body mass index (BMI) Read the entire page →
From page 194... ... , lymphomas Interview, 28 arising within, 56, 82, 148 Concurrent conditions, 63 Cervical cancer, invasive, 82 Conditions covered elsewhere in the Children, defining, 2n Listings, 10, 77–84 Children with HIV/AIDS cardiovascular disease, 10, 78–79, 84 concepts specific to, x, 10–12, 87–99, chronic kidney disease, including HIV 131–132 associated nephropathy, 10, 79–80, 84 mood disorders, with HIV, 91 diabetes, 10, 80–81, 84 proposed disabling CD4 count ranges hepatitis, 10, 81–82, 84 for children, 11 list of, 10, 78, 84 rationale for listing recommendations for malignancies not otherwise specified, 10, pediatric patients, 92–96 82–84 specialized evaluation of cases involving, Conditions currently without Listings, 9, 21 64–74 survival and prognosis, 88–92 diarrhea, 9, 64–66, 73 Children with HIV Early Antiretroviral distal sensory polyneuropathy, 9, 64, Therapy trial, 90 66–67, 74 Chronic conditions HIV-associated neurocognitive disorders associated with aging, 15 (HAND) , 9, 64, 67–69, 74 HIV infection as, ix, 33, 101 HIV-associated wasting syndrome, 9, 64, Chronic diarrhea, defining, 66 69–70, 74, 123 Chronic hepatitis, 81 Kaposi's sarcoma, 9, 64, 70–71, 74 Chronic inflammatory state, associated with lipoatrophy and lipohypertrophy, 9, 64, HIV infection, 33, 78 71–72, 74 Chronic kidney disease osteoporosis, 9, 64, 72–74 including HIV-associated nephropathy, Contrast-enhanced computed tomography 79–80 (CT) Read the entire page →
From page 195... ... disease, problems for children, 3 documenting, 114–115, 130 definition of disability, 16–17 five-step sequential evaluation process, 17–20 D-dimer levels, 34 initial decisions, 21 Data. See Disability data Disability examiners Data Collection on Adverse Events of Anti expertise of, 24 HIV Drugs Study, 78 reducing turnover in, 108 Death certificates, in which HIV disease was Disease progression, measures predictive underlying cause of death, 38 of, 45 Deidentified data. Read the entire page →
From page 196... ... , 68 of, ix most commonly affected domains of importance in determining disability, cognitive functioning, 68 63–65 HIV-associated wasting syndrome, 9, 64, improvements in, 39–41 69–70, 74, 123, 144, 151 Fusion inhibitors, 36 HIV disease Future revisions, potential areas for, 104 and aging, 35–36 as a disabling condition, ix Griffiths Mental Development Test, 91 documenting and evaluating, 112–113, Growth disturbances, 10–11, 88–89, 94, 129–131 138–139, 151 listed on death certificates as underlying Guidelines for the Management of Chronic cause of death, 38 Kidney Disease in HIV-Infected pathogenesis of, 34 Patients, 79 HIV Infection Listings, ix–x, 1–2, 24–26, 51, 122–124, 137–139. See also Halstead Category Test, 28 Introductory Text Hamilton Depression Inventory, 28 allowances by sublisting 14.08, 25 Health care professionals, allowing to allowances by sublisting 114.08, 25 provide input into the determination bacterial infections, 122, 137 process, xii, 13 current, 109–139 Hepatitis coinfection, 67, 80–82, 146–147 fungal infections, 122, 137 Hepatocellular carcinoma, 81, 83 helminthic infections, 122, 137 Highly active antiretroviral therapy most and least used sublistings of 14.08, (HAART) Read the entire page →
From page 197... ... , maximizing the utility of the HIV 7, 55, 59 Infection Listings, 101–103 place in the determination process, reflecting changes in the Listings in, 102 58–59 simplifying language in, xi, 102 primary central nervous system technical overview to, 103 lymphomas, 7, 56, 59 primary effusion lymphoma, 7, 57, 59 Kaposi's sarcoma (KS) , 45, 70–71, 82 progressive motor dysfunction, 94 progressive multifocal involving the pulmonary parenchyma, leukoencephalopathy (PML) Read the entire page →
From page 198... ... See Medication adherence SSA disability forms, 106 Nonnucleoside reverse transcriptase reevaluating the Listings, 103–105 inhibitors, 36, 83 research on functional assessment and "Nonspecific therapy," 66 return to work, 108 North American AIDS Cohort Collaboration training of disability examiners and on Research and Design medical consultants, 107–108 (NA ACCORD) , data from, 29, 65 use of data, 105 Notice of Proposed Rulemaking (NPRM) Read the entire page →
From page 199... ... , 19 Perinatal HIV Resistance in growing children and adolescents, transmitted, 104 complications of, 87–89 in treating patients with HIV infection, through breastfeeding, 87 37–38 Peripheral neuropathy, 66–67 Resistance mutations, 88, 104 Pharmacodynamics, individual, 104 Return-to-work patterns, for people with Physical domain, of functional assessment, HIV/AIDS, 40 27–28, 111 Revising the HIV Infection Listing, 5–12, Pneumocystis pneumonia (PCP) , 45, 47, 23–24 105 concepts specific to children, 10–12 reclassified, 24 imminently fatal or severely disabling Polyomavirus JC, 56 HIV-associated conditions, 7 Predictors, of response to treatment, x, 63 low CD4 count, 6–7 Primary central nervous system lymphomas, other severe HIV-associated conditions, 56, 82 7–10 Primary effusion lymphoma (PEL) Read the entire page →
From page 200... ... , 2, 16 Wasting syndrome, 9, 64, 69–70, 74, 123, Survival and prognosis, 88–92 144, 151 adherence and behavioral challenges, Weight loss. See also Wasting syndrome 91–92 involuntary, 69, 115–116, 139 complications of perinatal HIV in Western blot assay, 112, 128 growing children and adolescents, Wisconsin Card Sorting Test, 28 88–89 Women, HIV infection manifestations growth complications, 89 specific to, 115 metabolic complications, 89–90 Women's Interagency HIV Study, 81 neurologic complications, 90–91 Work prolonged despite HIV infection, ix–x ability to, 15, 63 Swiss HIV Cohort Study, 72, 81 defining "gainful," 2n, 16n Symptoms, consideration of, 118, 134–135 defining "substantial," 2n, 16 improvements in capacity to return to, T-cells. Read the entire page →

From page 193...

... , 21 Benefit amounts, and initial allowances, 17 Advanced Notice of Proposed Rulemaking Benton Visual Retention Test, 28 (ANPRM) , 23–24, 148 Blindness, 2n, 16n Age factors, 34 Body mass index (BMI)

Read the entire page →

From page 194...

... , lymphomas Interview, 28 arising within, 56, 82, 148 Concurrent conditions, 63 Cervical cancer, invasive, 82 Conditions covered elsewhere in the Children, defining, 2n Listings, 10, 77–84 Children with HIV/AIDS cardiovascular disease, 10, 78–79, 84 concepts specific to, x, 10–12, 87–99, chronic kidney disease, including HIV 131–132 associated nephropathy, 10, 79–80, 84 mood disorders, with HIV, 91 diabetes, 10, 80–81, 84 proposed disabling CD4 count ranges hepatitis, 10, 81–82, 84 for children, 11 list of, 10, 78, 84 rationale for listing recommendations for malignancies not otherwise specified, 10, pediatric patients, 92–96 82–84 specialized evaluation of cases involving, Conditions currently without Listings, 9, 21 64–74 survival and prognosis, 88–92 diarrhea, 9, 64–66, 73 Children with HIV Early Antiretroviral distal sensory polyneuropathy, 9, 64, Therapy trial, 90 66–67, 74 Chronic conditions HIV-associated neurocognitive disorders associated with aging, 15 (HAND) , 9, 64, 67–69, 74 HIV infection as, ix, 33, 101 HIV-associated wasting syndrome, 9, 64, Chronic diarrhea, defining, 66 69–70, 74, 123 Chronic hepatitis, 81 Kaposi's sarcoma, 9, 64, 70–71, 74 Chronic inflammatory state, associated with lipoatrophy and lipohypertrophy, 9, 64, HIV infection, 33, 78 71–72, 74 Chronic kidney disease osteoporosis, 9, 64, 72–74 including HIV-associated nephropathy, Contrast-enhanced computed tomography 79–80 (CT)

Read the entire page →

From page 195...

... disease, problems for children, 3 documenting, 114–115, 130 definition of disability, 16–17 five-step sequential evaluation process, 17–20 D-dimer levels, 34 initial decisions, 21 Data. See Disability data Disability examiners Data Collection on Adverse Events of Anti expertise of, 24 HIV Drugs Study, 78 reducing turnover in, 108 Death certificates, in which HIV disease was Disease progression, measures predictive underlying cause of death, 38 of, 45 Deidentified data.

Read the entire page →

From page 196...

... , 68 of, ix most commonly affected domains of importance in determining disability, cognitive functioning, 68 63–65 HIV-associated wasting syndrome, 9, 64, improvements in, 39–41 69–70, 74, 123, 144, 151 Fusion inhibitors, 36 HIV disease Future revisions, potential areas for, 104 and aging, 35–36 as a disabling condition, ix Griffiths Mental Development Test, 91 documenting and evaluating, 112–113, Growth disturbances, 10–11, 88–89, 94, 129–131 138–139, 151 listed on death certificates as underlying Guidelines for the Management of Chronic cause of death, 38 Kidney Disease in HIV-Infected pathogenesis of, 34 Patients, 79 HIV Infection Listings, ix–x, 1–2, 24–26, 51, 122–124, 137–139. See also Halstead Category Test, 28 Introductory Text Hamilton Depression Inventory, 28 allowances by sublisting 14.08, 25 Health care professionals, allowing to allowances by sublisting 114.08, 25 provide input into the determination bacterial infections, 122, 137 process, xii, 13 current, 109–139 Hepatitis coinfection, 67, 80–82, 146–147 fungal infections, 122, 137 Hepatocellular carcinoma, 81, 83 helminthic infections, 122, 137 Highly active antiretroviral therapy most and least used sublistings of 14.08, (HAART)

Read the entire page →

From page 197...

... , maximizing the utility of the HIV 7, 55, 59 Infection Listings, 101–103 place in the determination process, reflecting changes in the Listings in, 102 58–59 simplifying language in, xi, 102 primary central nervous system technical overview to, 103 lymphomas, 7, 56, 59 primary effusion lymphoma, 7, 57, 59 Kaposi's sarcoma (KS) , 45, 70–71, 82 progressive motor dysfunction, 94 progressive multifocal involving the pulmonary parenchyma, leukoencephalopathy (PML)

Read the entire page →

From page 198...

... See Medication adherence SSA disability forms, 106 Nonnucleoside reverse transcriptase reevaluating the Listings, 103–105 inhibitors, 36, 83 research on functional assessment and "Nonspecific therapy," 66 return to work, 108 North American AIDS Cohort Collaboration training of disability examiners and on Research and Design medical consultants, 107–108 (NA ACCORD) , data from, 29, 65 use of data, 105 Notice of Proposed Rulemaking (NPRM)

Read the entire page →

From page 199...

... , 19 Perinatal HIV Resistance in growing children and adolescents, transmitted, 104 complications of, 87–89 in treating patients with HIV infection, through breastfeeding, 87 37–38 Peripheral neuropathy, 66–67 Resistance mutations, 88, 104 Pharmacodynamics, individual, 104 Return-to-work patterns, for people with Physical domain, of functional assessment, HIV/AIDS, 40 27–28, 111 Revising the HIV Infection Listing, 5–12, Pneumocystis pneumonia (PCP) , 45, 47, 23–24 105 concepts specific to children, 10–12 reclassified, 24 imminently fatal or severely disabling Polyomavirus JC, 56 HIV-associated conditions, 7 Predictors, of response to treatment, x, 63 low CD4 count, 6–7 Primary central nervous system lymphomas, other severe HIV-associated conditions, 56, 82 7–10 Primary effusion lymphoma (PEL)

Read the entire page →

From page 200...

... , 2, 16 Wasting syndrome, 9, 64, 69–70, 74, 123, Survival and prognosis, 88–92 144, 151 adherence and behavioral challenges, Weight loss. See also Wasting syndrome 91–92 involuntary, 69, 115–116, 139 complications of perinatal HIV in Western blot assay, 112, 128 growing children and adolescents, Wisconsin Card Sorting Test, 28 88–89 Women, HIV infection manifestations growth complications, 89 specific to, 115 metabolic complications, 89–90 Women's Interagency HIV Study, 81 neurologic complications, 90–91 Work prolonged despite HIV infection, ix–x ability to, 15, 63 Swiss HIV Cohort Study, 72, 81 defining "gainful," 2n, 16n Symptoms, consideration of, 118, 134–135 defining "substantial," 2n, 16 improvements in capacity to return to, T-cells.

Read the entire page →

← Previous Chapter Skim

This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.

Index Pages 193-200

Index
Pages 193-200